Published

Management of Treatment-Resistant Depression: Challenges and Strategies.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2020-01-19
Source: Europe PMC
DOI: 10.2147/ndt.s198774
PubMed: 32021216

Authors

Voineskos D Daskalakis ZJ Blumberger DM.

Watch author

Derived topics and classifications

psilocybin Depression Addiction Mechanism of Action Aging Review Article Treatment-Resistant Depression Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31 Psilocybin to Manage Cancer-Related DepressionUnknown journal · 2016-12-20 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31 Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-02